2.815
3.60%
-0.105
Handel nachbörslich:
2.82
0.005
+0.18%
Finanzdaten der Akoya Biosciences Inc-Aktie (AKYA)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 |
Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
Revenues |
30.72%
18.35
|
26.49 | 25.21 | 23.52 | 21.41 |
Cost Of Revenue |
1.05%
9.971
|
9.867 | 9.939 | 11.40 | 9.117 |
Gross Profit |
49.58%
8.379
|
16.62 | 15.28 | 12.12 | 12.29 |
Operating Expenses
|
14.99%
29.96
|
26.06 | 26.83 | 31.36 | 29.73 |
Benefits Costs and Expenses |
11.95%
41.77
|
37.31 | 38.12 | 44.31 | 40.18 |
Costs And Expenses |
11.95%
41.77
|
37.31 | 38.12 | 44.31 | 40.18 |
Operating Income/Loss |
128.68%
-21.59
|
-9.439 | -11.55 | -19.24 | -17.44 |
Income/Loss From Continuing Operations Before Tax |
116.38%
-23.42
|
-10.82 | -12.90 | -20.79 | -18.77 |
Income Tax Expense/Benefit, Deferred |
0.037
|
- | - | - | - |
Income Tax Expense/Benefit |
386.36%
0.063
|
-0.022 | 0.015 | 0.018 | 0.029 |
Income/Loss From Continuing Operations After Tax |
117.40%
-23.48
|
-10.80 | -12.92 | -20.80 | -18.80 |
Net Income/Loss
|
117.40%
-23.48
|
-10.80 | -12.92 | -20.80 | -18.80 |
Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
Basic Average Shares |
2,713%
49.19
|
1.7485 | 48.98 | 40.64 | 38.33 |
Diluted Average Shares |
894.64%
49.19
|
4.9453 | 40.64 | 40.64 | 38.33 |
Basic Earnings Per Share |
140.00%
-0.48
|
-0.20 | -0.26 | -0.51 | -0.49 |
Diluted Earnings Per Share |
11.63%
-0.48
|
-0.43 | -0.51 | -0.51 | -0.49 |
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Kapitalisierung:
|
Volumen (24h):